Sunshine Riverhead Capital Investment Management Co., Ltd.
Xiamenriverheadcapital.cn
Overview
Sunshine Riverhead Capital Investment Management is a Chinese private equity firm established with an insurance background, focusing on investments in sectors such as healthcare, emerging technologies, and real estate.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| LncTAC Biotechnology Co., Ltd. | Jun 2026 | Series A | Co-investor |
| Rezubio Pharmaceuticals Co., Ltd. | Dec 2025 | Series A | Co-investor |
| Cascade Pharmaceuticals, Inc. | Nov 2025 | Series B | Co-investor |
| Wuxi Hisky Medical Technologies Co., Ltd. | Mar 2025 | Series D | Lead |
| AaltoSemi | Jan 2024 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
